Columbus Macro LLC Invests $3.18 Million in iShares Biotechnology ETF $IBB

Columbus Macro LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 18,825 shares of the financial services provider’s stock, valued at approximately $3,177,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in IBB. BNP Paribas Financial Markets boosted its position in shares of iShares Biotechnology ETF by 313.2% in the third quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock valued at $276,526,000 after acquiring an additional 1,451,820 shares during the period. Jefferies Financial Group Inc. bought a new position in iShares Biotechnology ETF during the third quarter worth about $65,083,000. JPMorgan Chase & Co. raised its stake in iShares Biotechnology ETF by 27.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock worth $153,039,000 after purchasing an additional 226,852 shares in the last quarter. Millennium Management LLC boosted its holdings in iShares Biotechnology ETF by 140.8% in the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after purchasing an additional 143,893 shares during the period. Finally, Caption Management LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter valued at about $11,333,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $160.41 on Monday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $179.64. The company’s 50 day moving average price is $171.17 and its two-hundred day moving average price is $164.38.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.